Literature DB >> 11967302

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

Takeshi Noda1, Hiroshi Sagara, Emiko Suzuki, Ayato Takada, Hiroshi Kida, Yoshihiro Kawaoka.   

Abstract

Using biochemical assays, it has been demonstrated that expression of Ebola virus VP40 alone in mammalian cells induced production of particles with a density similar to that of virions. To determine the morphological properties of these particles, cells expressing VP40 and the particles released from the cells were examined by electron microscopy. VP40 induced budding from the plasma membrane of filamentous particles, which differed in length but had uniform diameters of approximately 65 nm. When the Ebola virus glycoprotein (GP) responsible for receptor binding and membrane fusion was expressed in cells, we found pleomorphic particles budding from the plasma membrane. By contrast, when GP was coexpressed with VP40, GP was found on the filamentous particles induced by VP40. These results demonstrated the central role of VP40 in formation of the filamentous structure of Ebola virions and may suggest an interaction between VP40 and GP in morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967302      PMCID: PMC136157          DOI: 10.1128/jvi.76.10.4855-4865.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells.

Authors:  G Tran Van Nhieu; E Caron; A Hall; P J Sansonetti
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Authors:  H Jin; G P Leser; J Zhang; R A Lamb
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

3.  Morphopoietic determinants of HIV-1 Gag particles assembled in baculovirus-infected cells.

Authors:  B Gay; J Tournier; N Chazal; C Carrière; P Boulanger
Journal:  Virology       Date:  1998-08-01       Impact factor: 3.616

Review 4.  Marburg and Ebola viruses.

Authors:  H Feldmann; H D Klenk
Journal:  Adv Virus Res       Date:  1996       Impact factor: 9.937

5.  Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus.

Authors:  M J Schnell; L Buonocore; E Boritz; H P Ghosh; R Chernish; J K Rose
Journal:  EMBO J       Date:  1998-08-10       Impact factor: 11.598

6.  A system for functional analysis of Ebola virus glycoprotein.

Authors:  A Takada; C Robison; H Goto; A Sanchez; K G Murti; M A Whitt; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures.

Authors:  E C Coronel; K G Murti; T Takimoto; A Portner
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks.

Authors:  D Kobasa; M E Rodgers; K Wells; Y Kawaoka
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G.

Authors:  T Mebatsion; F Weiland; K K Conzelmann
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Release of viral glycoproteins during Ebola virus infection.

Authors:  V E Volchkov; V A Volchkova; W Slenczka; H D Klenk; H Feldmann
Journal:  Virology       Date:  1998-05-25       Impact factor: 3.616

View more
  169 in total

Review 1.  Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.

Authors:  Gavin C Bowick; Alexander J McAuley
Journal:  Bioeng Bugs       Date:  2011-05-01

2.  Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection.

Authors:  Graham Simmons; Andrew J Rennekamp; Ning Chai; Luk H Vandenberghe; James L Riley; Paul Bates
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.

Authors:  Ziying Han; Hani Boshra; J Oriol Sunyer; Susan H Zwiers; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.

Authors:  Jillian M Licata; Martha Simpson-Holley; Nathan T Wright; Ziying Han; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography.

Authors:  Tanmay A M Bharat; Takeshi Noda; James D Riches; Verena Kraehling; Larissa Kolesnikova; Stephan Becker; Yoshihiro Kawaoka; John A G Briggs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

6.  The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation.

Authors:  Takeshi Noda; Larissa Kolesnikova; Stephan Becker; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

7.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

8.  Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein.

Authors:  Masahiro Kajihara; Andrea Marzi; Eri Nakayama; Takeshi Noda; Makoto Kuroda; Rashid Manzoor; Keita Matsuno; Heinz Feldmann; Reiko Yoshida; Yoshihiro Kawaoka; Ayato Takada
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

9.  Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

Authors:  Rachel L Kaletsky; Joseph R Francica; Caroline Agrawal-Gamse; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

10.  Could the Ebola virus matrix protein VP40 be a drug target?

Authors:  Robert V Stahelin
Journal:  Expert Opin Ther Targets       Date:  2013-11-28       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.